Article
NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption.
European journal of clinical pharmacology - 1 Feb 2011
Kim Sang-Heon, Kim Sang-Hoon, Yoon Ho Joo, Shin Dong Ho, Park Sung Soo, Kim Youn-Seup, Park Jae-Seuk, Jee Young Koo
Abstract excerpt
PURPOSE: It has been suggested that drug-metabolizing enzymes might play important roles in the development of anti-tuberculosis drug (ATD)-induced maculopapular eruption (MPE), as in ATD-induced hepatitis. We investigated the associations between the genetic polymorphisms of drug-metabolizing enzymes and ATD-induced MPE. METHODS: We enrolled 62 patients with ATD-induced MPE (mean age 47.2 ± 19.0, male 59.7%) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
